Apramycin: Difference between revisions
Jump to navigation
Jump to search
m Protected "Apramycin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 8: | Line 8: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Apramycin''' (also ''Nebramycin II'') is an [[aminoglycoside]] [[antibiotic]]. | '''Apramycin''' (also ''Nebramycin II'') is an [[aminoglycoside]] [[antibiotic]]. | ||
Line 18: | Line 18: | ||
[[Category:Aminoglycoside antibiotics]] | [[Category:Aminoglycoside antibiotics]] | ||
[[de:Apramycin]] | [[de:Apramycin]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} |
Revision as of 22:25, 8 August 2012
WikiDoc Resources for Apramycin |
Articles |
---|
Most recent articles on Apramycin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Apramycin at Clinical Trials.gov Clinical Trials on Apramycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Apramycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Apramycin Discussion groups on Apramycin Directions to Hospitals Treating Apramycin Risk calculators and risk factors for Apramycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Apramycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Apramycin (also Nebramycin II) is an aminoglycoside antibiotic.